Pure Global AI
Manufacturer profile

ACTO GMBH

BrazilGermany2 ANVISA registrations1 unique technical categoryMar 30, 2026 – Mar 30, 2026
Verified
2
Total products
1
Technical names
Mar 2026
Earliest registration
Mar 2026
Latest registration
Regulatory footprint
Search ACTO GMBH across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
Debrider
Actolind® w Gel
Class IV · Mar 30, 2026
Debrider
Actolind® w Solution
Class IV · Mar 30, 2026
Most popular products
Products with most registrations
Debrider
2 registrations
Top registration holders
Companies holding product registrations for this manufacturer
IGI COMERCIO DE EQUIPAMENTOS ELETRONICOS LTDA
2 products
Top competitors
Companies with the most overlapping products (same technical names)
HELIANTO FARMACEUTICA LTDA
Brazil
4 registrations1 shared products
Shared products
Debrider
TAV TECH LTD
Israel
3 registrations1 shared products
Shared products
Debrider
B. BRAUN MEDICAL AG - SUIÇA
Switzerland
3 registrations1 shared products
Shared products
Debrider
MARDEN MEDICAL LTDA
Brazil
2 registrations1 shared products
Shared products
Debrider
CALLE MED PRODUTOS MEDICOS E HOSPITALARES LTDA
Brazil
2 registrations1 shared products
Shared products
Debrider
About this profile

Explore comprehensive manufacturer profile for ACTO GMBH based in Germany through Pure Global AI's free Brazil medical device database. This manufacturer has 2 products registered with ANVISA across 1 unique technical categories. Their regulatory history spans from Mar 30, 2026 to Mar 30, 2026.

This page provides detailed insights including 2 recent product registrations including Debrider, 1 most popular products with Debrider having 2 registrations, 1 registration holders including IGI COMERCIO DE EQUIPAMENTOS ELETRONICOS LTDA, and 5 key competitors with HELIANTO FARMACEUTICA LTDA sharing 1 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.